Pyridine carboxamide orexin receptor antagonists

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C546S262000

Reexamination Certificate

active

08003797

ABSTRACT:
The present invention is directed to pyridyl carboxamide compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved.

REFERENCES:
patent: 2002/0147198 (2002-10-01), Chen et al.
patent: 2009/0088452 (2009-04-01), Coleman et al.
patent: 2010/0035931 (2010-02-01), Coleman et al.
patent: 2010/0063056 (2010-03-01), Coleman et al.
patent: WO2007/061763 (2007-05-01), None
patent: WO2008/108991 (2008-09-01), None
patent: WO2010051236 (2010-05-01), None
Silverman, R. “The Organic Chemistry of Drug Design and Drug Action,” 2004, Elsevier, pp. 29-32.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pyridine carboxamide orexin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyridine carboxamide orexin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridine carboxamide orexin receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2765256

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.